Category: Blood Diseases
Blood Diseases market research reports by Global Market Insights
-
Hemostasis Products Market Size By Product (Topical Hemostasis Product {Gelatin, Polysaccharides , Oxidized Regenerated Cellulose, Collagen}), Infusible Hemostasis Products {Platelet Concentrate From Donor Blood, Fresh Frozen Plasma (FFP), Factor VIII, Prothrombin}), Advanced Hemostasis Products ({Flowable, Thrombin, Synthetic Sealants, Fibrin}), By Application (Trauma, Surgery, Hemophilia, Myocardial Infarction), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
Hemostasis Products Market Size By Product (Topical Hemostasis Product {Gelatin, Polysaccharides , Oxidized Regenerated Cellulose, Collagen}), Infusible Hemostasis Products {Platelet Concentrate From Donor Blood, Fresh Frozen Plasma (FFP), Factor VIII, Prothrombin}), Advanced Hemostasis Products ({F ... Read More
-
Blood and Blood Components Market Size By Product (Whole Blood, Blood Components {Red Blood Cells, Platelets, Plasma, White Blood Cells}), By Application (Anaemia, Trauma & Surgery, Cancer Treatment, Bleeding Disorders), By End-Use (Hospitals, Ambulatory Surgical Centres), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028
Blood and Blood Components Market Size By Product (Whole Blood, Blood Components {Red Blood Cells, Platelets, Plasma, White Blood Cells}), By Application (Anaemia, Trauma & Surgery, Cancer Treatment, Bleeding Disorders), By End-Use (Hospitals, Ambulatory Surgical Centres), Industry Analysis Report, ... Read More
-
Hemophilia Treatment Market Size By Disease (Hemophilia A {Severe, Moderate, Mild}, Hemophilia B {Severe, Moderate, Mild}), By Product (Recombinant Factor Concentrates {Factor VIII, Factor IX}, Plasma-derived Factor Concentrates {Factor VIII, Factor IX}, Extended Half-life Products {Factor VIII, Factor IX}), By Patient (Pediatric {0 to 4, 5 to 13, 14 to18}, Adult {19 to 44, 45+}), By Treatment (Prophylaxis, On Demand), By Therapy (Factor Replacement Therapy, Non-factor Replacement Therapy), By Drug Class (Vasopressin, Coagulation Factors), By Route of Administration (Injectable, Nasal Spray), By End-use (Hospitals, Clinics, Hemophilia Treatment Centers), Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
Hemophilia Treatment Market Size By Disease (Hemophilia A {Severe, Moderate, Mild}, Hemophilia B {Severe, Moderate, Mild}), By Product (Recombinant Factor Concentrates {Factor VIII, Factor IX}, Plasma-derived Factor Concentrates {Factor VIII, Factor IX}, Extended Half-life Products {Factor VIII, Fac ... Read More